Cardiac Mapping Market - Major Technological Revolution is Expected by 2024

 Overview:

The study involved four major activities in estimating the current size of the cardiac mapping market. Exhaustive secondary research was done to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the total market size. After that, the market breakdown and data triangulation was used to estimate the market size of segments and subsegments.

Recent Developments:

# In 2019, Acutuc medical partnered with Peerbridge Health, US. Under the partnership, Peerbridge Health offered its advanced ambulatory ECG—Peerbridge Cor that has been cleared to detect up to 26 different arrhythmias to be used with the AcQMap System.

# In 2018, Royal Philips acquired EPD Solutions, Israel, an innovator in image-guided procedures for cardiac arrhythmias.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89853405

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiac mapping market. These methods were also used extensively to determine the extent of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research
# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size-using the market size estimation processes as explained above-the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the cardiac mapping industry.

Projected Growth in Revenue Generation

The global cardiac mapping market size is expected to grow from USD 1.4 billion in 2019 to USD 2.1 billion by 2024, at a CAGR of 8.7% during the forecast period.

Major Growth Boosting Factors:

Growth in the cardiac mapping industry is driven primarily by factors such as new entrants in the market, growing investments, funds, and grants, increasing incidence of target diseases, and growth in the geriatric population.

Key Questions Addressed by the Report:

# Which of the product segments will dominate the cardiac mapping market in the next five years?
# Emerging countries have immense opportunities for the growth and adoption of cardiac mapping. Will this scenario continue in the next five years?
# What are the upcoming technologies in the cardiac mapping market?
# Which indication segment will dominate the cardiac mapping market in the next five years?
# What will be the effect of the developments undertaken by market players?

Geographical Growth Scenario:

The APAC cardiac mapping market to grow at the highest CAGR during the forecast period

While North America is expected to dominate the global cardiac mapping industry in 2019, the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the large population, increasing geriatric population, the growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, and growing demand for advanced technologies.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=89853405

Key Market Players

The major vendors in the cardiac mapping market include Biosense Webster (US), Abbott (US),  and Boston Scientific Corporation (US). These leading players offer a strong suit of products for cardiac mapping and have a broad geographic presence. The other players in this market include Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical  (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System  (Germany).